Literature DB >> 20412275

Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy.

Marcia Maria Oliveira Lima1, Maria Carmo P Nunes, Manoel O C Rocha, Francilu Rodrigues Beloti, Maria Clara N Alencar, Antônio Luiz P Ribeiro.   

Abstract

UNLABELLED: Parameters of diastolic function have been shown to correlate with exercise capacity (EC) in individuals with impaired left ventricular (LV) systolic function. However, the role of LV diastolic function in predicting EC in Chagas cardiomyopathy has not been reported.
OBJECTIVES: This study aimed to determine the relationship between LV diastolic parameters assessed by echocardiography and EC in patients with Chagas cardiomyopathy.
METHODS: We studied 40 patients (23 men; 49 + or - 8 years), with diagnosis of Chagas disease and dilated cardiomyopathy. Medical therapy was individually adjusted according to standardized guidelines. Methods of acquiring two-dimensional Doppler, tissue Doppler imaging (TDI), and their measurements were described. Exercise testing was performed by a Bruce protocol. Brain natriuretic peptide (BNP) levels were also determined.
RESULTS: Most patients (63%) were in NYHA functional class I. Mean peak oxygen consumption estimated (peakVO(2)) was 31.7 + or - 10.2 mL/kg per minute, and mean left ventricular ejection fraction (LVEF) was 36.3 + or - 7.8%. Univariate analysis showed that various echocardiographic parameters of diastolic function were correlated with peakVO(2). There was no correlation between BNP levels or LVEF and EC. Multivariate analysis, after adjustment for age and gender, revealed that E/E' ratio and left atrial volume (LAV), emerged as independent predictors of EC, as demonstrated in the model: peakVO(2)= 60.825 + (0.439 x LAV) - (1.620 x E/E' ratio) - (0.483 x age) - (4.821 x female gender). The R(2) of this model was 0.52.
CONCLUSIONS: Functional capacity assessed by peakVO(2) was related to increase LV filling pressures, independently on systolic function in patients with Chagas cardiomyopathy. (Echocardiography 2010;27:519-524).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412275     DOI: 10.1111/j.1540-8175.2009.01081.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

1.  Effects of Trypanosoma cruzi infection on myocardial morphology, single cardiomyocyte contractile function and exercise tolerance in rats.

Authors:  Rômulo D Novaes; Arlete R Penitente; Reggiani V Gonçalves; André Talvani; Clóvis A Neves; Izabel R S C Maldonado; Antônio J Natali
Journal:  Int J Exp Pathol       Date:  2011-07-08       Impact factor: 1.925

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 4.  Treatment of Chagas cardiomyopathy.

Authors:  Fernando A Botoni; Antonio Luiz P Ribeiro; Carolina Coimbra Marinho; Marcia Maria Oliveira Lima; Maria do Carmo Pereira Nunes; Manoel Otávio C Rocha
Journal:  Biomed Res Int       Date:  2013-11-24       Impact factor: 3.411

5.  The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function.

Authors:  Giovane R Sousa; Juliana A S Gomes; Marcos Paulo S Damasio; Maria Carmo P Nunes; Henrique S Costa; Nayara I Medeiros; Rafaelle C G Fares; Ana Thereza Chaves; Rodrigo Corrêa-Oliveira; Manoel Otávio C Rocha
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

6.  Determinants of Functional Capacity in Patients with Chagas Disease.

Authors:  Whesley Tanor Silva; Henrique Silveira Costa; Pedro Henrique Scheidt Figueiredo; Márcia Maria Oliveira Lima; Vanessa Pereira Lima; Fábio Silva Martins da Costa; Matheus Ribeiro Ávila; Vanessa Amaral Mendonça; Ana Cristina Rodrigues Lacerda; Maria Carmo Pereira Nunes; Manoel Otávio Costa Rocha
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.